These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 30209803)
1. Pharmacotherapy of obesity - state of the art. Matyjaszek-Matuszek B; Szafraniec A; Porada D Endokrynol Pol; 2018; 69(4):. PubMed ID: 30209803 [TBL] [Abstract][Full Text] [Related]
2. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis. Khera R; Murad MH; Chandar AK; Dulai PS; Wang Z; Prokop LJ; Loomba R; Camilleri M; Singh S JAMA; 2016 Jun; 315(22):2424-34. PubMed ID: 27299618 [TBL] [Abstract][Full Text] [Related]
4. Obesity: The New Global Epidemic Pharmacological Treatment, Opportunities and Limits for Personalized Therapy. Milano W; De Biasio V; Di Munzio W; Foggia G; Capasso A Endocr Metab Immune Disord Drug Targets; 2020; 20(8):1232-1243. PubMed ID: 32410565 [TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of obesity: Available medications and drugs under investigation. Pilitsi E; Farr OM; Polyzos SA; Perakakis N; Nolen-Doerr E; Papathanasiou AE; Mantzoros CS Metabolism; 2019 Mar; 92():170-192. PubMed ID: 30391259 [TBL] [Abstract][Full Text] [Related]
6. Current and emerging pharmacotherapies for obesity in Australia. Hocking S; Dear A; Cowley MA Obes Res Clin Pract; 2017; 11(5):501-521. PubMed ID: 28818558 [TBL] [Abstract][Full Text] [Related]
8. Drug safety evaluation of naltrexone/bupropion for the treatment of obesity. Verpeut JL; Bello NT Expert Opin Drug Saf; 2014 Jun; 13(6):831-41. PubMed ID: 24766397 [TBL] [Abstract][Full Text] [Related]
9. Drug treatment of obesity: current status and future prospects. Kakkar AK; Dahiya N Eur J Intern Med; 2015 Mar; 26(2):89-94. PubMed ID: 25634851 [TBL] [Abstract][Full Text] [Related]
10. [Status of pharmacotherapy in current care of obese]. Sucharda P Cas Lek Cesk; 2017; 156(6):319-322. PubMed ID: 29212337 [TBL] [Abstract][Full Text] [Related]
11. New obesity agents: lorcaserin and phentermine/topiramate. Fleming JW; McClendon KS; Riche DM Ann Pharmacother; 2013; 47(7-8):1007-16. PubMed ID: 23800750 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological management of obesity in pediatric patients. Boland CL; Harris JB; Harris KB Ann Pharmacother; 2015 Feb; 49(2):220-32. PubMed ID: 25366340 [TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of Obesity: Clinical Trials to Clinical Practice. Gadde KM; Pritham Raj Y Curr Diab Rep; 2017 May; 17(5):34. PubMed ID: 28378293 [TBL] [Abstract][Full Text] [Related]
14. Overview of new antiobesity drugs. Hainer V Expert Opin Pharmacother; 2014 Oct; 15(14):1975-8. PubMed ID: 25100293 [TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized controlled trials of anti-obesity drugs. Singh AK; Singh R Expert Rev Clin Pharmacol; 2020 Jan; 13(1):53-64. PubMed ID: 31770497 [No Abstract] [Full Text] [Related]
16. Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles. Krentz AJ; Fujioka K; Hompesch M Diabetes Obes Metab; 2016 Jun; 18(6):558-70. PubMed ID: 26936802 [TBL] [Abstract][Full Text] [Related]
17. Drugs to treat obesity: do they work? Kim S Postgrad Med J; 2016 Jul; 92(1089):401-6. PubMed ID: 27053517 [TBL] [Abstract][Full Text] [Related]
18. Update on obesity pharmacotherapy. Bray GA; Ryan DH Ann N Y Acad Sci; 2014 Apr; 1311():1-13. PubMed ID: 24641701 [TBL] [Abstract][Full Text] [Related]
19. A Comparison of New Pharmacological Agents for the Treatment of Obesity. Nuffer W; Trujillo JM; Megyeri J Ann Pharmacother; 2016 May; 50(5):376-88. PubMed ID: 26887340 [TBL] [Abstract][Full Text] [Related]